Protara Therapeutics (TARA) Preferred Dividend Payments (2013 - 2017)

Protara Therapeutics' Preferred Dividend Payments history runs 3 years deep, the most recent figure standing at $6.7 million for Q3 2017.

• In Q3 2017, Preferred Dividend Payments changed N/A year-over-year to $6.7 million; the TTM figure through Sep 2017 stood at $18.4 million (changed N/A YoY), while the FY2014 annual figure was $6.4 million, up 3.82% from the prior year.
• Preferred Dividend Payments was $6.7 million for Q3 2017 at Protara Therapeutics, down from $12.0 million in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $12.0 million in Q4 2014 to a low of -$2.3 million in Q3 2014.
• Historically, Preferred Dividend Payments has averaged $3.3 million across 3 years, with a median of $1.5 million in 2013.
• Biggest YoY gain for Preferred Dividend Payments was 681.75% in 2014; the steepest drop was 247.86% in 2014.
• A 3-year view of Preferred Dividend Payments shows it stood at $1.5 million in 2013, then surged by 681.75% to $12.0 million in 2014, then tumbled by 43.96% to $6.7 million in 2017.
• The last three Preferred Dividend Payments figures came in at $6.7 million (Q3 2017), $12.0 million (Q4 2014), and -$2.3 million (Q3 2014), per Business Quant data.